Japanese Journal of Radiology

, Volume 37, Issue 3, pp 255–263 | Cite as

Efficacy and prognostic factors of transarterial embolization as initial treatment for spontaneously ruptured hepatocellular carcinoma: a single-center retrospective analysis in 57 patients

  • Chun Zhou
  • Qing-Quan Zu
  • Bin Wang
  • Chun-Gao Zhou
  • Hai-Bin Shi
  • Sheng LiuEmail author
Original Article



To evaluate the efficacy and prognostic factors following transarterial embolization (TAE) as initial treatment for spontaneously ruptured hepatocellular carcinoma (HCC).


From June 2012 to June 2016, a total of 57 spontaneously ruptured HCC patients who received TAE as initial therapy were retrospectively studied at our institution. Patients were followed until October 2016. Survival rates were estimated using the Kaplan–Meier method, and prognostic factors related to survival were evaluated using Cox regression analysis.


Among them, 8 (14.0%) patients died within 30 days after initial TAE. The median overall survival time was 208 days. The 6-month, 1-year, and 2-year cumulative overall survival rates were 50.3%, 35.9%, and 14.7%, respectively. Multivariate analysis indicated that tumor size [HR (hazard ratio) 1.12; 95% CI (confidence interval) 1.02–1.23, P = 0.022] Child–Pugh class (HR 1.78; 95% CI 1.13–2.80; P = 0.013), absence of shock on admission (HR 0.40; 95% CI 0.17–0.95; P = 0.039), and embolization with lipiodol and gelatin sponge particles (HR 0.33; 95% CI 0.16–0.70; P = 0.004) were independent prognostic factors for survival.


TAE appeared to be an effective initial treatment for spontaneously ruptured HCC. The results indicated that large tumors, poor Child–Pugh class, and shock on admission were associated with poor prognosis. For these patients, embolization with lipiodol and gelatin sponge particles could achieve better survival than PVA particles used.


Hepatocellular carcinoma Prognostic factors Spontaneous rupture Transarterial embolization 



We would like to thank Jin LIU from the First Affiliated Hospital of Nanjing Medical University for his Statistical Work.



Compliance with ethical standards

Conflict of interest

No conflict of interest to declare.


  1. 1.
    Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res. 2016;46:13–21.CrossRefGoogle Scholar
  2. 2.
    Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg. 2006;141:191–8.CrossRefGoogle Scholar
  3. 3.
    Aoki T, Kokudo N, Matsuyama Y, Izumi N, Ichida T, Kudo M, Ku Y, Sakamoto M, Nakashima O, Matsui O, Makuuchi M, Liver Cancer Study Group of J. Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg. 2014;259:532–4.CrossRefGoogle Scholar
  4. 4.
    Xia F, Lau WY, Qian C, Ma K, Li X, Bie P. Continuous occlusion of hepatic artery proper for prevention of blood loss in partial hepatectomy for ruptured hepatocellular carcinoma: a case-matched comparative study. Ann Surg Oncol. 2011;18:1638–43.CrossRefGoogle Scholar
  5. 5.
    Lee HS, Choi GH, Kang DR, Han KH, Ahn SH, Kim DY, Park JY, Kim SU, Choi JS. Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy. World J Surg. 2014;38:2070–8.CrossRefGoogle Scholar
  6. 6.
    Hsueh KC, Fan HL, Chen TW, Chan DC, Yu JC, Tsou SS, Chang TM, Hsieh CB. Management of spontaneously ruptured hepatocellular carcinoma and hemoperitoneum manifested as acute abdomen in the emergency room. World J Surg. 2012;36:2670–6.CrossRefGoogle Scholar
  7. 7.
    Kim JY, Lee JS, Oh DH, Yim YH, Lee HK. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2012;24:640–5.CrossRefGoogle Scholar
  8. 8.
    Kirikoshi H, Saito S, Yoneda M, Fujita K, Mawatari H, Uchiyama T, Higurashi T, Imajo K, Sakaguchi T, Atsukawa K, Sawabe A, Kanesaki A, Takahashi H, Abe Y, Inamori M, Kobayashi N, Kubota K, Ueno N, Nakajima A. Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study. BMC Gastroenterol. 2009;9:29–3.CrossRefPubMedCentralGoogle Scholar
  9. 9.
    Chan WH, Hung CF, Pan KT, Lui KW, Huang YT, Lin SY, Lin YY, Wu TH, Yu MC. Impact of spontaneous tumor rupture on prognosis of patients with T4 hepatocellular carcinoma. J Surg Oncol. 2016;113:789–95.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Schwarz L, Bubenheim M, Zemour J, Herrero A, Muscari F, Ayav A, Riboud R, Ducerf C, Regimbeau JM, Tranchart H, Lermite E, Petrovai G, Suhol A, Doussot A, Capussotti L, Tuech JJ, Le Treut YP, Association F. Bleeding recurrence and mortality following interventional management of spontaneous HCC rupture: results of a Multicenter European Study. World J Surg. 2018;42:225–32.CrossRefGoogle Scholar
  11. 11.
    Darnis B, Rode A, Mohkam K, Ducerf C, Mabrut JY. Management of bleeding liver tumors. J Visc Surg. 2014;151:365–7.CrossRefGoogle Scholar
  12. 12.
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. American Association for the Study of Liver Diseases (AASLD) practice guideline. Hepatology. 2011;53:1020–35.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Kudo M, Kitano M, Sakurai T, Nishida N. General rules for the clinical and pathological study of primary liver cancer, nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the Liver Cancer Study Group of Japan. Dig Dis. 2015;33:765–70.CrossRefGoogle Scholar
  14. 14.
    Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford). 2000;2:333–9.CrossRefGoogle Scholar
  15. 15.
    Shin BS, Park MH, Jeon GS. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization. Acta Radiol. 2011;52:331–5.CrossRefGoogle Scholar
  16. 16.
    Yamakado K, Miyayama S, Hirota S, Mizunuma K, Nakamura K, Inaba Y, et al. Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis? Jpn J Radiol. 2012;30:560–6.CrossRefGoogle Scholar
  17. 17.
    Sada H, Ohira M, Kobayashi T, Tashiro H, Chayama K, Ohdan H. An analysis of surgical treatment for the spontaneous rupture of hepatocellular carcinoma. Dig Surg. 2016;33:43–50.CrossRefGoogle Scholar
  18. 18.
    Buczkowski AK, Kim PT, Ho SG, Schaeffer DF, Lee SI, Owen DA, Weiss AH, Chung SW, Scudamore CH. Multidisciplinary management of ruptured hepatocellular carcinoma. J Gastrointest Surg. 2006;10:379–86.CrossRefGoogle Scholar
  19. 19.
    Battula N, Madanur M, Priest O, Srinivasan P, O'Grady J, Heneghan MA, Bowles M, Muiesan P, Heaton N, Rela M. Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg. 2009;197:164–7.CrossRefGoogle Scholar
  20. 20.
    Medsinge A, Zajko A, Orons P, Amesur N, Santos E. A case-based approach to common embolization agents used in vascular interventional radiology. AJR. 2014;203:699–708.CrossRefGoogle Scholar
  21. 21.
    Osuga K, Maeda N, Higashihara H, Hori S, Nakazawa T, Tanaka K, Nakamura M, Kishimoto K, Ono Y, Tomiyama N. Current status of embolic agents for liver tumor embolization. Int J Clin Oncol. 2012;17:306–15.CrossRefGoogle Scholar
  22. 22.
    Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, et al. Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014;32:242–50.CrossRefGoogle Scholar
  23. 23.
    Lee MY, Chuang VP, Wei CJ, Cheng TY, Cherng MT. Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes. Eur J Radiol. 2012;81:1976–9.CrossRefGoogle Scholar

Copyright information

© Japan Radiological Society 2018

Authors and Affiliations

  • Chun Zhou
    • 1
  • Qing-Quan Zu
    • 1
  • Bin Wang
    • 1
  • Chun-Gao Zhou
    • 1
  • Hai-Bin Shi
    • 1
  • Sheng Liu
    • 1
    Email author
  1. 1.Department of Interventional Radiologythe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina

Personalised recommendations